Drug Trial Radar · NCT00848770
Manipulation of Arterial Pressure in Acute Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: Dec 31, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
240
Planned (sponsor's estimate)
Start
Jan 2008
Primary completion
Dec 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- Hospital de Clinicas de Porto AlegreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 20, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a controlled clinical trial among non thrombolysed acute ischemic stroke patients to determine the effects of three levels of arterial pressure on death and neurological disability. After the admission in the vascular unit of the Emergency Department the patients are randomized to maintain during the first 24h the Systolic Arterial Pressure in tree levels of pressure: 140 to 160 mmHg; 161 to 180 mmHg and 181 to 200 mmHg. The end point of the study is the Modified Rankin score and mortality in three month after the discharge.
Conditions
- Stroke, Acute
Interventions
Esmolol, Sodium Nitroprussiate (NPS) or Norepinephrine (NOR)Drug
Esmolol(2,5g /10ml + SG5% 240ml = 10mg/ml). Start with a bolus of 500mcg/kg in 1 min (ou 0,5mg/kg)and maintain the dose of 50mcg/kg/min (or 0,05mg/kg/min). Increase de infusion in 25mcg/kg/min after each 5 min until the randomized SAP or if the heart beat is lower than 60. The maximum dose is 200ug/kg/min (ou 0,2 mg/kg/min). If the randomized SAP do not reach the goal pressure with the maximum dose of esmolol, start a infusion of sodium nitroprussiate (NPS). NPS (50mg + SG5% 250ml= 200mcg/ml). No bolus. Start the infusion with 0,2 mcg/kg/min and maintain 0,5 a 5mcg/kg/min. Increase de dose each 15 min to a maximum of 10mcg/kg/min. NOR: (8mg/8ml + SG5% 242ml=32mcg/ml)No bolus. Start 1 to 5 mcg/min to a maximum dose of 20mcg/min.
Esmolol, NPS or NORDrug
We use one of the three drug to manipulate the systolic arterial pressure
manipulation of SAPDrug
Esmolol or NPS or NOR
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ranking score and mortalityTime frame: Three month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital de Clínicas de Porto Alegre/ UFRGS
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.